Fast Market Research recommends "Nigeria Pharmaceuticals & Healthcare Report Q1 2015" from Business Monitor International, now available

Boston, MA -- (SBWire) -- 12/02/2014 --The Nigerian government remains committed to improving healthcare quality and infrastructure across the country. The formation of the National Health Insurance Scheme (NHIS) has seen a growing number of citizens enrolled since its formation in 2005, albeit lower than previously anticipated. We believe Nigeria's pharmaceutical market has the capacity for considerable future growth in the long term due to its increasing population and high burden of disease. Despite this, scant healthcare funding, weak patent protection and low per capita spending will continue to impede the market's potential.

Headline Expenditure Projections

- Pharmaceuticals: NGN203.66bn (USD1.28bn) in 2013 to NGN234.71bn (USD1.44bn) in 2014; +15.2% in local currency terms and +12.8% in US dollar terms. Forecast revised down from last quarter to better suit current market conditions.

- Healthcare: NGN2,792.53bn (USD17.54bn) in 2013 to NGN3,091.82bn (USD19.01bn) in 2014; +10.7% in local currency terms and +8.4% in US dollar terms.

View Full Report Details and Table of Contents

Risk/Reward Index:

Nigeria's Q115 Pharmaceutical Risk/Reward Index (RRI) score of 37.1, places it 21 ^st in the Middle East and Africa matrix. Nigeria is regarded as a low-reward, high-risk proposition for multinationals due to drug counterfeiting, corruption and poor pharmaceutical regulations governing the market.

Key Trends And Developments

October

Patients in Nigeria are being forced to seek medical treatment abroad due to the poor condition of the healthcare system in the country, reports allAfrica. Most of the country's private hospitals, which provide 60% of health services, lack necessary modern equipment. Nigerians seek medical treatment overseas based on the belief that hospitals in other countries have better medical equipment for diagnosis and treatment. Around 18,000 Nigerians are reported to have spent NGN14.6bn (USD88.9mn) on medical treatment in India in 2013.

Over 7.2mn citizens have enrolled and benefited from the...

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 800-844-8156

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Slovenia Pharmaceuticals & Healthcare Report Q1 2015
- Thailand Pharmaceuticals & Healthcare Report Q1 2015
- Kenya Pharmaceuticals & Healthcare Report Q1 2015
- Hong Kong Pharmaceuticals & Healthcare Report Q1 2015
- Croatia Pharmaceuticals & Healthcare Report Q1 2015
- Sweden Pharmaceuticals & Healthcare Report Q1 2015
- Bulgaria Pharmaceuticals & Healthcare Report Q1 2015
- Algeria Pharmaceuticals & Healthcare Report Q1 2015
- Italy Pharmaceuticals & Healthcare Report Q1 2015
- Pakistan Pharmaceuticals & Healthcare Report Q1 2015